Kidney Cancer and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Kidney Cancer Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Kidney Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Kidney Cancer Overall Market Size
2.1 Global Kidney Cancer Market Size: 2023 VS 2030
2.2 Global Kidney Cancer Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Kidney Cancer Players in Global Market
3.2 Top Global Kidney Cancer Companies Ranked by Revenue
3.3 Global Kidney Cancer Revenue by Companies
3.4 Top 3 and Top 5 Kidney Cancer Companies in Global Market, by Revenue in 2023
3.5 Global Companies Kidney Cancer Product Type
3.6 Tier 1, Tier 2, and Tier 3 Kidney Cancer Players in Global Market
3.6.1 List of Global Tier 1 Kidney Cancer Companies
3.6.2 List of Global Tier 2 and Tier 3 Kidney Cancer Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global Kidney Cancer Market Size Markets, 2023 & 2030
4.1.2 Surgery
4.1.3 Immunotherapy
4.1.4 Targeted Therapy
4.1.5 Other
4.2 Segmentation by Type - Global Kidney Cancer Revenue & Forecasts
4.2.1 Segmentation by Type - Global Kidney Cancer Revenue, 2019-2024
4.2.2 Segmentation by Type - Global Kidney Cancer Revenue, 2025-2030
4.2.3 Segmentation by Type - Global Kidney Cancer Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global Kidney Cancer Market Size, 2023 & 2030
5.1.2 Renal Cell Carcinoma
5.1.3 Renal Pelvis Cancer
5.1.4 Other
5.2 Segmentation by Application - Global Kidney Cancer Revenue & Forecasts
5.2.1 Segmentation by Application - Global Kidney Cancer Revenue, 2019-2024
5.2.2 Segmentation by Application - Global Kidney Cancer Revenue, 2025-2030
5.2.3 Segmentation by Application - Global Kidney Cancer Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Kidney Cancer Market Size, 2023 & 2030
6.2 By Region - Global Kidney Cancer Revenue & Forecasts
6.2.1 By Region - Global Kidney Cancer Revenue, 2019-2024
6.2.2 By Region - Global Kidney Cancer Revenue, 2025-2030
6.2.3 By Region - Global Kidney Cancer Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Kidney Cancer Revenue, 2019-2030
6.3.2 United States Kidney Cancer Market Size, 2019-2030
6.3.3 Canada Kidney Cancer Market Size, 2019-2030
6.3.4 Mexico Kidney Cancer Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Kidney Cancer Revenue, 2019-2030
6.4.2 Germany Kidney Cancer Market Size, 2019-2030
6.4.3 France Kidney Cancer Market Size, 2019-2030
6.4.4 U.K. Kidney Cancer Market Size, 2019-2030
6.4.5 Italy Kidney Cancer Market Size, 2019-2030
6.4.6 Russia Kidney Cancer Market Size, 2019-2030
6.4.7 Nordic Countries Kidney Cancer Market Size, 2019-2030
6.4.8 Benelux Kidney Cancer Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Kidney Cancer Revenue, 2019-2030
6.5.2 China Kidney Cancer Market Size, 2019-2030
6.5.3 Japan Kidney Cancer Market Size, 2019-2030
6.5.4 South Korea Kidney Cancer Market Size, 2019-2030
6.5.5 Southeast Asia Kidney Cancer Market Size, 2019-2030
6.5.6 India Kidney Cancer Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Kidney Cancer Revenue, 2019-2030
6.6.2 Brazil Kidney Cancer Market Size, 2019-2030
6.6.3 Argentina Kidney Cancer Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Kidney Cancer Revenue, 2019-2030
6.7.2 Turkey Kidney Cancer Market Size, 2019-2030
6.7.3 Israel Kidney Cancer Market Size, 2019-2030
6.7.4 Saudi Arabia Kidney Cancer Market Size, 2019-2030
6.7.5 UAE Kidney Cancer Market Size, 2019-2030
7 Companies Profiles
7.1 Merck
7.1.1 Merck Corporate Summary
7.1.2 Merck Business Overview
7.1.3 Merck Kidney Cancer Major Product Offerings
7.1.4 Merck Kidney Cancer Revenue in Global Market (2019-2024)
7.1.5 Merck Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Kidney Cancer Major Product Offerings
7.2.4 Novartis Kidney Cancer Revenue in Global Market (2019-2024)
7.2.5 Novartis Key News & Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Corporate Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb Kidney Cancer Major Product Offerings
7.3.4 Bristol-Myers Squibb Kidney Cancer Revenue in Global Market (2019-2024)
7.3.5 Bristol-Myers Squibb Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Corporate Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Kidney Cancer Major Product Offerings
7.4.4 Pfizer Kidney Cancer Revenue in Global Market (2019-2024)
7.4.5 Pfizer Key News & Latest Developments
7.5 Roche
7.5.1 Roche Corporate Summary
7.5.2 Roche Business Overview
7.5.3 Roche Kidney Cancer Major Product Offerings
7.5.4 Roche Kidney Cancer Revenue in Global Market (2019-2024)
7.5.5 Roche Key News & Latest Developments
7.6 Amgen
7.6.1 Amgen Corporate Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Kidney Cancer Major Product Offerings
7.6.4 Amgen Kidney Cancer Revenue in Global Market (2019-2024)
7.6.5 Amgen Key News & Latest Developments
7.7 Aveo Pharmaceuticals
7.7.1 Aveo Pharmaceuticals Corporate Summary
7.7.2 Aveo Pharmaceuticals Business Overview
7.7.3 Aveo Pharmaceuticals Kidney Cancer Major Product Offerings
7.7.4 Aveo Pharmaceuticals Kidney Cancer Revenue in Global Market (2019-2024)
7.7.5 Aveo Pharmaceuticals Key News & Latest Developments
7.8 Bayer
7.8.1 Bayer Corporate Summary
7.8.2 Bayer Business Overview
7.8.3 Bayer Kidney Cancer Major Product Offerings
7.8.4 Bayer Kidney Cancer Revenue in Global Market (2019-2024)
7.8.5 Bayer Key News & Latest Developments
7.9 Exelixis
7.9.1 Exelixis Corporate Summary
7.9.2 Exelixis Business Overview
7.9.3 Exelixis Kidney Cancer Major Product Offerings
7.9.4 Exelixis Kidney Cancer Revenue in Global Market (2019-2024)
7.9.5 Exelixis Key News & Latest Developments
7.10 Eisai
7.10.1 Eisai Corporate Summary
7.10.2 Eisai Business Overview
7.10.3 Eisai Kidney Cancer Major Product Offerings
7.10.4 Eisai Kidney Cancer Revenue in Global Market (2019-2024)
7.10.5 Eisai Key News & Latest Developments
7.11 Hikma Pharmaceuticals
7.11.1 Hikma Pharmaceuticals Corporate Summary
7.11.2 Hikma Pharmaceuticals Business Overview
7.11.3 Hikma Pharmaceuticals Kidney Cancer Major Product Offerings
7.11.4 Hikma Pharmaceuticals Kidney Cancer Revenue in Global Market (2019-2024)
7.11.5 Hikma Pharmaceuticals Key News & Latest Developments
7.12 Sun Pharmaceutical
7.12.1 Sun Pharmaceutical Corporate Summary
7.12.2 Sun Pharmaceutical Business Overview
7.12.3 Sun Pharmaceutical Kidney Cancer Major Product Offerings
7.12.4 Sun Pharmaceutical Kidney Cancer Revenue in Global Market (2019-2024)
7.12.5 Sun Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Kidney Cancer Market Opportunities & Trends in Global Market
Table 2. Kidney Cancer Market Drivers in Global Market
Table 3. Kidney Cancer Market Restraints in Global Market
Table 4. Key Players of Kidney Cancer in Global Market
Table 5. Top Kidney Cancer Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Kidney Cancer Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Kidney Cancer Revenue Share by Companies, 2019-2024
Table 8. Global Companies Kidney Cancer Product Type
Table 9. List of Global Tier 1 Kidney Cancer Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Kidney Cancer Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. Segmentation by Type � Global Kidney Cancer Revenue, (US$, Mn), 2023 & 2030
Table 12. Segmentation by Type - Global Kidney Cancer Revenue (US$, Mn), 2019-2024
Table 13. Segmentation by Type - Global Kidney Cancer Revenue (US$, Mn), 2025-2030
Table 14. Segmentation by Application� Global Kidney Cancer Revenue, (US$, Mn), 2023 & 2030
Table 15. Segmentation by Application - Global Kidney Cancer Revenue, (US$, Mn), 2019-2024
Table 16. Segmentation by Application - Global Kidney Cancer Revenue, (US$, Mn), 2025-2030
Table 17. By Region� Global Kidney Cancer Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Kidney Cancer Revenue, (US$, Mn), 2019-2024
Table 19. By Region - Global Kidney Cancer Revenue, (US$, Mn), 2025-2030
Table 20. By Country - North America Kidney Cancer Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Kidney Cancer Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Kidney Cancer Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Kidney Cancer Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Kidney Cancer Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Kidney Cancer Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Kidney Cancer Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Kidney Cancer Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Kidney Cancer Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Kidney Cancer Revenue, (US$, Mn), 2025-2030
Table 30. Merck Corporate Summary
Table 31. Merck Kidney Cancer Product Offerings
Table 32. Merck Kidney Cancer Revenue (US$, Mn) & (2019-2024)
Table 33. Merck Key News & Latest Developments
Table 34. Novartis Corporate Summary
Table 35. Novartis Kidney Cancer Product Offerings
Table 36. Novartis Kidney Cancer Revenue (US$, Mn) & (2019-2024)
Table 37. Novartis Key News & Latest Developments
Table 38. Bristol-Myers Squibb Corporate Summary
Table 39. Bristol-Myers Squibb Kidney Cancer Product Offerings
Table 40. Bristol-Myers Squibb Kidney Cancer Revenue (US$, Mn) & (2019-2024)
Table 41. Bristol-Myers Squibb Key News & Latest Developments
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Kidney Cancer Product Offerings
Table 44. Pfizer Kidney Cancer Revenue (US$, Mn) & (2019-2024)
Table 45. Pfizer Key News & Latest Developments
Table 46. Roche Corporate Summary
Table 47. Roche Kidney Cancer Product Offerings
Table 48. Roche Kidney Cancer Revenue (US$, Mn) & (2019-2024)
Table 49. Roche Key News & Latest Developments
Table 50. Amgen Corporate Summary
Table 51. Amgen Kidney Cancer Product Offerings
Table 52. Amgen Kidney Cancer Revenue (US$, Mn) & (2019-2024)
Table 53. Amgen Key News & Latest Developments
Table 54. Aveo Pharmaceuticals Corporate Summary
Table 55. Aveo Pharmaceuticals Kidney Cancer Product Offerings
Table 56. Aveo Pharmaceuticals Kidney Cancer Revenue (US$, Mn) & (2019-2024)
Table 57. Aveo Pharmaceuticals Key News & Latest Developments
Table 58. Bayer Corporate Summary
Table 59. Bayer Kidney Cancer Product Offerings
Table 60. Bayer Kidney Cancer Revenue (US$, Mn) & (2019-2024)
Table 61. Bayer Key News & Latest Developments
Table 62. Exelixis Corporate Summary
Table 63. Exelixis Kidney Cancer Product Offerings
Table 64. Exelixis Kidney Cancer Revenue (US$, Mn) & (2019-2024)
Table 65. Exelixis Key News & Latest Developments
Table 66. Eisai Corporate Summary
Table 67. Eisai Kidney Cancer Product Offerings
Table 68. Eisai Kidney Cancer Revenue (US$, Mn) & (2019-2024)
Table 69. Eisai Key News & Latest Developments
Table 70. Hikma Pharmaceuticals Corporate Summary
Table 71. Hikma Pharmaceuticals Kidney Cancer Product Offerings
Table 72. Hikma Pharmaceuticals Kidney Cancer Revenue (US$, Mn) & (2019-2024)
Table 73. Hikma Pharmaceuticals Key News & Latest Developments
Table 74. Sun Pharmaceutical Corporate Summary
Table 75. Sun Pharmaceutical Kidney Cancer Product Offerings
Table 76. Sun Pharmaceutical Kidney Cancer Revenue (US$, Mn) & (2019-2024)
Table 77. Sun Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. Kidney Cancer Product Picture
Figure 2. Kidney Cancer Segment by Type in 2023
Figure 3. Kidney Cancer Segment by Application in 2023
Figure 4. Global Kidney Cancer Market Overview: 2022
Figure 5. Key Caveats
Figure 6. Global Kidney Cancer Market Size: 2023 VS 2030 (US$, Mn)
Figure 7. Global Kidney Cancer Revenue: 2019-2030 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by Kidney Cancer Revenue in 2023
Figure 9. Segmentation by Type � Global Kidney Cancer Revenue, (US$, Mn), 2023 & 2030
Figure 10. Segmentation by Type - Global Kidney Cancer Revenue Market Share, 2019-2030
Figure 11. Segmentation by Application � Global Kidney Cancer Revenue, (US$, Mn), 2023 & 2030
Figure 12. Segmentation by Application - Global Kidney Cancer Revenue Market Share, 2019-2030
Figure 13. By Region - Global Kidney Cancer Revenue Market Share, 2019-2030
Figure 14. By Country - North America Kidney Cancer Revenue Market Share, 2019-2030
Figure 15. United States Kidney Cancer Revenue, (US$, Mn), 2019-2030
Figure 16. Canada Kidney Cancer Revenue, (US$, Mn), 2019-2030
Figure 17. Mexico Kidney Cancer Revenue, (US$, Mn), 2019-2030
Figure 18. By Country - Europe Kidney Cancer Revenue Market Share, 2019-2030
Figure 19. Germany Kidney Cancer Revenue, (US$, Mn), 2019-2030
Figure 20. France Kidney Cancer Revenue, (US$, Mn), 2019-2030
Figure 21. U.K. Kidney Cancer Revenue, (US$, Mn), 2019-2030
Figure 22. Italy Kidney Cancer Revenue, (US$, Mn), 2019-2030
Figure 23. Russia Kidney Cancer Revenue, (US$, Mn), 2019-2030
Figure 24. Nordic Countries Kidney Cancer Revenue, (US$, Mn), 2019-2030
Figure 25. Benelux Kidney Cancer Revenue, (US$, Mn), 2019-2030
Figure 26. By Region - Asia Kidney Cancer Revenue Market Share, 2019-2030
Figure 27. China Kidney Cancer Revenue, (US$, Mn), 2019-2030
Figure 28. Japan Kidney Cancer Revenue, (US$, Mn), 2019-2030
Figure 29. South Korea Kidney Cancer Revenue, (US$, Mn), 2019-2030
Figure 30. Southeast Asia Kidney Cancer Revenue, (US$, Mn), 2019-2030
Figure 31. India Kidney Cancer Revenue, (US$, Mn), 2019-2030
Figure 32. By Country - South America Kidney Cancer Revenue Market Share, 2019-2030
Figure 33. Brazil Kidney Cancer Revenue, (US$, Mn), 2019-2030
Figure 34. Argentina Kidney Cancer Revenue, (US$, Mn), 2019-2030
Figure 35. By Country - Middle East & Africa Kidney Cancer Revenue Market Share, 2019-2030
Figure 36. Turkey Kidney Cancer Revenue, (US$, Mn), 2019-2030
Figure 37. Israel Kidney Cancer Revenue, (US$, Mn), 2019-2030
Figure 38. Saudi Arabia Kidney Cancer Revenue, (US$, Mn), 2019-2030
Figure 39. UAE Kidney Cancer Revenue, (US$, Mn), 2019-2030
Figure 40. Merck Kidney Cancer Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 41. Novartis Kidney Cancer Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Bristol-Myers Squibb Kidney Cancer Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Pfizer Kidney Cancer Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Roche Kidney Cancer Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Amgen Kidney Cancer Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Aveo Pharmaceuticals Kidney Cancer Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Bayer Kidney Cancer Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Exelixis Kidney Cancer Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Eisai Kidney Cancer Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Hikma Pharmaceuticals Kidney Cancer Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Sun Pharmaceutical Kidney Cancer Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Industry Market Size
